These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8386930

  • 1. Congenital and acquired syndromes of apparent mineralocorticoid excess.
    Edwards CR, Walker BR, Benediktsson R, Seckl JR.
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
    [Abstract] [Full Text] [Related]

  • 2. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
    Edwards CR, Stewart PM.
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
    [Abstract] [Full Text] [Related]

  • 3. Apparent mineralocorticoid excess syndromes.
    Shimojo M, Stewart PM.
    J Endocrinol Invest; 1995 Nov; 18(7):518-32. PubMed ID: 9221270
    [Abstract] [Full Text] [Related]

  • 4. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM, Corrie JE, Shackleton CH, Edwards CR.
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [Abstract] [Full Text] [Related]

  • 5. Apparent mineralocorticoid excess.
    Benediktsson R, Edwards CR.
    J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
    [Abstract] [Full Text] [Related]

  • 6. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
    Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR.
    Lancet; 1987 Oct 10; 2(8563):821-4. PubMed ID: 2889032
    [Abstract] [Full Text] [Related]

  • 7. The specificity of the human mineralocorticoid receptor: clinical clues to a biological conundrum.
    Edwards CR, Burt D, Stewart PM.
    J Steroid Biochem; 1989 Jan 10; 32(1B):213-6. PubMed ID: 2536449
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB, Stewart PM.
    J Hypertens Suppl; 1996 Dec 10; 14(5):S19-24. PubMed ID: 9120678
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC, Mune T, Rogerson FM, Kayes KM, Agarwal AK.
    Pediatr Res; 1997 Jan 10; 41(1):25-9. PubMed ID: 8979285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Organ-specific actions of 11 beta-hydroxysteroid dehydrogenase in humans: implications for the pathophysiology of hypertension.
    Walker BR.
    Steroids; 1994 Feb 10; 59(2):84-9. PubMed ID: 8191553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P, Lovati E, Frey FJ.
    J Hypertens; 2000 Mar 10; 18(3):241-8. PubMed ID: 10726708
    [Abstract] [Full Text] [Related]

  • 20. The cortisol-cortisone shuttle and hypertension.
    Stewart PM, Edwards CR.
    J Steroid Biochem Mol Biol; 1991 Mar 10; 40(4-6):501-9. PubMed ID: 1958552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.